Table of Contents

February 2018, Volume 25, Number 2

Editorial

    • Serisha Moodley,
    • Frank Weber,
    • and Lois M Mulligan

    The evolving clinical, genetic and therapeutic landscape of multiple endocrine neoplasia type 2

    Endocr Relat Cancer 25 (2) E1-E4, doi:10.1530/ERC-17-0488

Thematic Review

    • Samuel A Wells, Jr

    Advances in the management of MEN2: from improved surgical and medical treatment to novel kinase inhibitors

    Endocr Relat Cancer 25 (2) T1-T13, doi:10.1530/ERC-17-0325 first published on 15 November 2017
    • Carole Guerin,
    • Pauline Romanet,
    • David Taieb,
    • Thierry Brue,
    • André Lacroix,
    • Frederic Sebag,
    • Anne Barlier,
    • and Frederic Castinetti

    Looking beyond the thyroid: advances in the understanding of pheochromocytoma and hyperparathyroidism phenotypes in MEN2 and of non-MEN2 familial forms

    Endocr Relat Cancer 25 (2) T15-T28, doi:10.1530/ERC-17-0266 first published on 5 September 2017
    • Frederic Castinetti,
    • Jeffrey Moley,
    • Lois Mulligan,
    • and Steven G Waguespack

    A comprehensive review on MEN2B

    Endocr Relat Cancer 25 (2) T29-T39, doi:10.1530/ERC-17-0209 first published on 11 July 2017
    • Andreas Machens and
    • Henning Dralle

    Advances in risk-oriented surgery for multiple endocrine neoplasia type 2

    Endocr Relat Cancer 25 (2) T41-T52, doi:10.1530/ERC-17-0202 first published on 7 September 2017
    • Sara Redaelli,
    • Ivan Plaza-Menacho,
    • and Luca Mologni

    Novel targeted therapeutics for MEN2

    Endocr Relat Cancer 25 (2) T53-T68, doi:10.1530/ERC-17-0297
    • Joanna Grey and
    • Kym Winter

    Patient quality of life and prognosis in multiple endocrine neoplasia type 2

    Endocr Relat Cancer 25 (2) T69-T77, doi:10.1530/ERC-17-0335 first published on 24 October 2017
    • Iván Plaza-Menacho

    Structure and function of RET in multiple endocrine neoplasia type 2

    Endocr Relat Cancer 25 (2) T79-T90, doi:10.1530/ERC-17-0354 first published on 24 November 2017
    • Tirtha K Das and
    • Ross L Cagan

    Non-mammalian models of multiple endocrine neoplasia type 2

    Endocr Relat Cancer 25 (2) T91-T104, doi:10.1530/ERC-17-0411
    • Maria Domenica Castellone and
    • Rosa Marina Melillo

    RET-mediated modulation of tumor microenvironment and immune response in multiple endocrine neoplasia type 2 (MEN2)

    Endocr Relat Cancer 25 (2) T105-T119, doi:10.1530/ERC-17-0303 first published on 20 September 2017

Review

    • Enzo Lalli and
    • Michaela Luconi

    The next step: mechanisms driving adrenocortical carcinoma metastasis

    Endocr Relat Cancer 25 (2) R31-R48, doi:10.1530/ERC-17-0440 first published on 15 November 2017
    • Priya Gopie,
    • Lin Mei,
    • Anthony C Faber,
    • Steven R Grossman,
    • Steven C Smith,
    • and Sosipatros A Boikos

    Classification of gastrointestinal stromal tumor syndromes

    Endocr Relat Cancer 25 (2) R49-R58, doi:10.1530/ERC-17-0329 first published on 23 November 2017
    • Avaniyapuram Kannan Murugan,
    • Arasambattu Kannan Munirajan,
    • and Ali S Alzahrani

    Long noncoding RNAs: emerging players in thyroid cancer pathogenesis

    Endocr Relat Cancer 25 (2) R59-R82, doi:10.1530/ERC-17-0188 first published on 16 November 2017
    • Philipp Y Maximov,
    • Balkees Abderrahman,
    • Ramona F Curpan,
    • Yousef M Hawsawi,
    • Ping Fan,
    • and V Craig Jordan

    A unifying biology of sex steroid-induced apoptosis in prostate and breast cancers

    Endocr Relat Cancer 25 (2) R83-R113, doi:10.1530/ERC-17-0416 first published on 21 November 2017
    OPEN ACCESS ARTICLE

Research

    • Tiffany Scully,
    • Carolyn D Scott,
    • Sue M Firth,
    • Lisa M Sedger,
    • John E Pintar,
    • Stephen M Twigg,
    • and Robert C Baxter

    Enhancement of mammary tumour growth by IGFBP-3 involves impaired T cell accumulation

    Endocr Relat Cancer 25 (2) 111-122, doi:10.1530/ERC-17-0384 first published on 7 December 2017
    • Louis W C Chow,
    • Satoshi Morita,
    • Christopher Y C Chow,
    • Wai-Kuen Ng,
    • and Masakazu Toi

    Neoadjuvant palbociclib on ER+ breast cancer (N007): clinical response and EndoPredict’s value

    Endocr Relat Cancer 25 (2) 123-130, doi:10.1530/ERC-17-0396 first published on 20 November 2017
    OPEN ACCESS ARTICLE
    • Y Capodanno,
    • F O Buishand,
    • L Y Pang,
    • J Kirpensteijn,
    • J A Mol,
    • and D J Argyle

    Notch pathway inhibition targets chemoresistant insulinoma cancer stem cells

    Endocr Relat Cancer 25 (2) 131-144, doi:10.1530/ERC-17-0415 first published on 24 November 2017
    • Sara Molatore,
    • Andrea Kügler,
    • Martin Irmler,
    • Tobias Wiedemann,
    • Frauke Neff,
    • Annette Feuchtinger,
    • Johannes Beckers,
    • Mercedes Robledo,
    • Federico Roncaroli,
    • and Natalia S Pellegata

    Characterization of neuroendocrine tumors in heterozygous mutant MENX rats: a novel model of invasive medullary thyroid carcinoma

    Endocr Relat Cancer 25 (2) 145-162, doi:10.1530/ERC-17-0456 first published on 15 November 2017

Research Letter

    • Paula Fontes Asprino,
    • Rudinei Diogo Marques Linck,
    • Jônatas Cesar,
    • Florêncio Porto Freitas,
    • Fernanda Christtanini Koyama,
    • Rachel Simões Pimenta Riechelmann,
    • Frederico Perego Costa,
    • Paulo Marcelo Gehm Hoff,
    • Pedro Alexandre Favoretto Galante,
    • Diogo Meyer,
    • Anamaria Aranha Camargo,
    • and Jorge Sabbaga

    TSC2 rare germline variants in non-tuberous sclerosis patients with neuroendocrine neoplasias

    Endocr Relat Cancer 25 (2) L1-L5, doi:10.1530/ERC-17-0286 first published on 22 November 2017
    OPEN ACCESS ARTICLE
|

This Issue

February 2018; 25 (2)
Cover
  1. Editorial
  2. Thematic Review
  3. Review
  4. Research
  5. Research Letter

Find articles in this issue containing these words:

New Articles: issue in progress

  1. July 2018, 25 (7)
  1. Current Issue
  1. Alert me to new issues of Endocrine-Related Cancer

Most